Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human (tested or 100% immunogen sequence identity)
Specificity and Use
XCL1/2 antibody was raised against synthetic peptide C-RDVVRSMDRKSNTRN from an internal region of human Chemokine (C Motif) Ligand 1/2 (XCL1/XCL2) (NP_002986.1; NP_003166.1). Percent identity by BLAST analysis: Human, Gorilla (100%); Monkey (87%).
LS-E26995 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-C108895. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
Human Chemokine (C Motif) Ligand 1/2 (XCL1/XCL2). XCL1 and CXL2 are almost identical and therefore this antibody is expected to recognize both proteins.
Western Blot: Preliminary experiments gave an approx 80kD band in Human Peripheral Blood Mononucleocytes lysates after 0.3 ug/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 12.5kD according to NP_002986.1 and 12.6kD according to 003166.1. The 80kD band was successfully blocked by incubation with the immunizing peptide. Have any further splice variants/modified forms been reported?